Utah Medical Products EBIT

Utah Medical Products (UTMD) currently reports a EBIT of $12M as of June 2026. That compares with $15M in the prior-year period — down 23.1% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Utah Medical Products's EBIT history and peer comparisons.

Utah Medical Products's EBIT decreased from $15M to $12M — a 23.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Utah Medical Products's EBIT of $12M is lower than the Healthcare sector average of $23B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Utah Medical Products reported $12M in EBIT as of June 2026. That compares with $15M in the prior-year period — down 23.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Utah Medical Products, and consider following UTMD for alerts when major investors trade the stock.